Profile data is unavailable for this security.
About the company
RetinalGenix Technologies Inc. is an ophthalmic research and development company. The Company is focused on creating solutions to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders and to enable the early detection and treatment of multiple systemic diseases through a combination of therapeutic medications and medical device technologies. The Company is focused on preventing vision loss and blindness due to ocular diseases, including diabetic retinopathy and maculopathy, in its first two devices: Retinal Imaging Screening Device and RetinalCam. Retinal Imaging Screening Device is a portable, retinal imaging system providing a wide field of view without requiring pupil dilation. RetinalCam is an in-home/remote location patient-activated monitoring and imaging device offering real time communication and alerting system for physicians available 24/7. The Company is also engaged in the development of its product candidates: RTG-2023 and RTG-2024.
- Revenue in USD (TTM)0.00
- Net income in USD-4.04m
- Incorporated2017
- Employees0.00
- LocationRetinalGenix Technologies Inc1450 North Mcdowell Boulevard, Suite 150PETALUMA 94954United StatesUSA
- Phone+1 (415) 578-9583
- Fax+1 (302) 645-1280
- Websitehttps://retinalgenix.com/index.php/contact
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| enVVeno Medical Corp | 0.00 | -21.24m | 57.87m | 31.00 | -- | 1.22 | -- | -- | -1.33 | -1.33 | 0.00 | 2.70 | 0.00 | -- | -- | 0.00 | -54.12 | -58.43 | -57.23 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
| Champions Oncology Inc | 51.66m | -3.40m | 58.05m | 210.00 | -- | -- | -- | 1.12 | -0.2541 | -0.2541 | 3.78 | -0.0244 | 1.88 | -- | 5.75 | 245,976.20 | -12.39 | -10.00 | -44.43 | -23.00 | 44.27 | 46.58 | -6.58 | -6.04 | -- | -- | 333.00 | -- | -6.90 | 13.13 | -36.38 | -- | 0.0479 | -- |
| Atara Biotherapeutics Inc | 100.44m | -133.16m | 60.09m | 159.00 | -- | -- | -- | 0.5982 | -26.44 | -26.44 | 18.00 | -15.77 | 0.606 | 1.69 | 134.10 | 446,395.60 | -80.34 | -70.20 | -276.19 | -86.94 | 82.70 | -- | -132.58 | -1,559.33 | 0.4993 | -46.83 | -- | -- | -86.51 | -- | -20.95 | -- | -49.14 | -- |
| Bioqual Inc | -100.00bn | -100.00bn | 60.37m | 108.00 | -- | 1.63 | -- | -- | -- | -- | -- | 41.34 | -- | -- | -- | -- | -- | 8.14 | -- | 9.52 | -- | 19.36 | -- | 7.13 | -- | -- | 0.00 | 21.43 | -5.27 | 11.79 | -84.12 | -25.26 | 1.60 | 10.76 |
| Cue Biopharma Inc | 9.53m | -44.61m | 62.01m | 53.00 | -- | 2.44 | -- | 6.51 | -0.906 | -0.906 | 0.1925 | 0.4213 | 0.1677 | -- | 3.96 | 179,849.10 | -78.47 | -57.45 | -111.95 | -68.41 | -- | -- | -468.02 | -810.87 | -- | -- | 0.1726 | -- | 340.88 | 36.88 | 4.30 | -- | -- | -- |
| X4 Pharmaceuticals Inc | 1.12m | -16.76m | 62.08m | 93.00 | -- | 1.04 | -- | 55.28 | -0.0853 | -0.0853 | 0.0056 | 0.3538 | 0.0064 | -- | 1.53 | 12,075.27 | -9.54 | -61.53 | -11.29 | -69.20 | 55.92 | -- | -1,492.34 | -13,288.93 | 4.80 | -- | 0.5579 | -- | -- | -- | -4.93 | -- | 12.03 | -- |
| Immuneering Corp | 0.00 | -58.07m | 62.57m | 66.00 | -- | 1.14 | -- | -- | -1.97 | -1.97 | 0.00 | 1.86 | 0.00 | -- | -- | 0.00 | -63.66 | -- | -68.36 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -5.86 | -- | -- | -- |
| Celularity Inc | 42.69m | -112.83m | 62.66m | 120.00 | -- | 2.25 | -- | 1.47 | -5.77 | -5.77 | 2.14 | 1.27 | 0.2236 | 3.92 | 4.65 | 355,750.00 | -59.09 | -19.19 | -90.61 | -20.99 | 60.24 | -- | -264.30 | -454.79 | 0.2182 | -11.18 | 0.5958 | -- | 26.68 | -- | -1,483.14 | -- | -- | -- |
| RetinalGenix Technologies Inc | 0.00 | -4.04m | 62.99m | 0.00 | -- | -- | -- | -- | -0.2291 | -0.2291 | 0.00 | -0.101 | 0.00 | -- | -- | -- | -9,059.05 | -9,163.75 | -- | -- | -- | -- | -- | -- | -- | -1,050.46 | -- | -- | -- | -- | 46.58 | -- | -- | -- |
| Spero Therapeutics Inc | 106.46m | 3.51m | 64.32m | 46.00 | 19.54 | 0.9867 | 17.94 | 0.6042 | 0.0609 | 0.0609 | 1.97 | 1.21 | 0.8788 | -- | 3.78 | 2,314,239.00 | 2.90 | -35.52 | 4.19 | -41.75 | -- | -- | 3.30 | -124.40 | -- | -- | 0.00 | -- | 93.95 | 92.11 | 149.14 | -- | -- | -- |
| Allovir Inc | 0.00 | -100.20m | 65.86m | 112.00 | -- | 0.5433 | -- | -- | -0.8755 | -0.8755 | 0.00 | 1.05 | 0.00 | -- | -- | 0.00 | -54.04 | -52.85 | -59.58 | -57.72 | -- | -- | -- | -378,613.90 | -- | -- | 0.00 | -- | -- | -- | -12.87 | -- | -- | -- |
| Agenus Inc | 160.43m | -227.86m | 67.09m | 389.00 | -- | -- | -- | 0.4182 | -11.06 | -11.06 | 7.81 | -13.48 | 0.559 | -- | 259.38 | 412,408.80 | -81.56 | -55.02 | -663.00 | -115.31 | 99.61 | -- | -145.89 | -102.92 | -- | -0.7247 | -- | -- | 59.47 | 33.56 | -11.66 | -- | 22.58 | -- |
| Bioatla Inc | 11.00m | -81.82m | 67.20m | 65.00 | -- | 2.93 | -- | 6.11 | -1.70 | -1.70 | 0.2284 | 0.4751 | 0.103 | -- | -- | 169,230.80 | -76.61 | -48.72 | -103.22 | -57.35 | -- | -- | -743.79 | -6,651.71 | -- | -- | 0.00 | -- | -- | -- | -15.95 | -- | -37.01 | -- |
| CytomX Therapeutics Inc | 126.62m | 13.83m | 67.81m | 120.00 | 5.17 | -- | 4.33 | 0.5356 | 0.1675 | 0.1675 | 1.52 | -0.2998 | 0.7031 | -- | 43.88 | 1,055,142.00 | 7.68 | -21.53 | 29.38 | -32.32 | -- | -- | 10.92 | -100.38 | -- | -- | -- | -- | 90.38 | 11.21 | 99.43 | -- | -26.01 | -- |
| ALX Oncology Holdings Inc | 0.00 | -151.16m | 68.04m | 89.00 | -- | 0.4973 | -- | -- | -2.98 | -2.98 | 0.00 | 2.59 | 0.00 | -- | -- | 0.00 | -74.50 | -34.34 | -89.35 | -36.47 | -- | -- | -- | -7,238.76 | -- | -- | 0.0851 | -- | -- | -- | -30.23 | -- | 14.30 | -- |
